Skip to main content

CADENCE DESIGN SYSTEMS INC

For the period ended Dec 31, 2024. Filed Feb 21, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 21, 2025

CDNS$336.53+5.2%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

(a) 3. Exhibits

EXHIBIT INDEX

Incorporated by Reference
Exhibit · Exhibit · Filing · Provided
NumberExhibit TitleFormFile No.No.DateHerewith
2.1Share Purchase Agreement related to BETA CAE Systems International AG and BETA CAE Systems SA, dated March 2, 2024.10-Q000-158672.14/24/2024
3.1The Registrant’s Restated Certificate of Incorporation, as filed with the Secretary of State of the State of Delaware on May 3, 2024.8-K000-158673.15/6/2024
3.2The Registrant’s Amended and Restated Bylaws, effective as of November 2, 2023.8-K000-158673.111/3/2023
4.1Specimen Certificate of the Registrant’s Common Stock.S-4033-434004.0110/17/1991
4.2Base Indenture, dated September 10, 2024, by and between the Registrant and U.S. Bank Trust Company, National Association, as trustee.8-K000-158674.19/10/2024
4.3First Supplemental Indenture, dated September 10, 2024, by and between the Registrant and U.S. Bank Trust Company, National Association, as trustee (including the Form of 4.200% Senior Notes due 2027, the Form of 4.300% Senior Notes due 2029 and the Form of 4.700% Senior Notes due 2034).8-K000-158674.29/10/2024
4.4Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934.X
10.1*The Registrant’s 1995 Directors Stock Incentive Plan.10-Q001-1586710.017/26/2012
10.2*Form of Stock Option Agreement, as currently in effect under the Registrant’s 1995 Directors Stock Incentive Plan.10-K000-1586710.762/21/2013
10.3*Form of Incentive Stock Award Agreement, as currently in effect under the Registrant’s 1995 Directors Stock Incentive Plan.10-K000-1586710.772/21/2013
10.4*The Registrant’s Omnibus Equity Incentive Plan, as amended and restated.S-8333-27514099.0110/23/2023
10.5*Form of Incentive Stock Award Agreement for Non-Executive Employees and Consultants, as currently in effect under the Registrant’s Omnibus Equity Incentive Plan.10-Q000-1586710.27/24/2024
10.6*Form of Restricted Stock Unit Agreement for Non-Executive Employees and Consultants, as currently in effect under the Registrant’s Omnibus Equity Incentive Plan.10-Q000-1586710.37/24/2024
10.7*Form of Stock Option Agreement for Non-Executive Employees and Consultants, as currently in effect under the Registrant’s Omnibus Equity Incentive Plan.S-8333-19577199.045/7/2014
10.8*Form of Incentive Stock Award Agreement for Executives, as currently in effect under the Registrant’s Omnibus Equity Incentive Plan.S-8333-19577199.055/7/2014
10.9*Form of Restricted Stock Unit Agreement for Executives, as currently in effect under the Registrant’s Omnibus Equity Incentive Plan.S-8333-19577199.065/7/2014
10.10*Form of Stock Option Agreement for Executives, as currently in effect under the Registrant’s Omnibus Equity Incentive Plan.S-8333-19577199.075/7/2014
10.11*nusemi inc. 2015 Equity Incentive Plan.S-8333-22629499.017/23/2018
10.12*The Registrant’s Amended and Restated Employee Stock Purchase Plan.S-8333-28288499.110/30/2024
10.13*The Registrant’s 2009 Deferred Compensation Plan, as amended and restated on February 5, 2019.10-K000-1586710.262/24/2020
10.14*The Registrant’s Senior Executive Bonus Plan.8-K000-1586710.012/8/2019
10.15*The Registrant’s Executive Severance Plan.8-K001-1586710.015/11/2016
10.16*The Registrant’s Director Medical and Prescription Benefits Coverage Reimbursement Plan.10-Q001-1060610.024/29/2011
10.17*Form of Indemnity Agreement between the Registrant and its directors and executive officers, as amended and restated.10-Q000-1586710.017/25/2016
10.18*Transition and Release Agreement, dated May 2, 2024, between the Registrant and Neil Zaman.10-Q000-1586710.44/24/2024
10.19*Amended and Restated Employment Agreement, effective as of December 15, 2021, between the Registrant and Anirudh Devgan.8-K/A000-1586710.0112/17/2021
10.20Credit Agreement, dated as of June 30, 2021, by and among the Registrant, Bank of America, N.A., and other lenders party thereto.8-K000-1586710.017/1/2021
10.21First Amendment to Credit Agreement, dated September 7, 2022, by and among the Registrant, Bank of America, N.A. and other lenders party thereto.8-K000-1586710.029/8/2022
10.22Credit Agreement, dated August 14, 2024, by and among the Registrant, Bank of America, N.A., as a lender and administrative agent, the other lenders and issuing banks party thereto and BofA Securities, Inc., JPMorgan Chase Bank, N.A. and HSBC Bank USA, National Association, as joint lead arrangers and joint bookrunners.8-K000-1586710.18/15/2024
10.23Loan Agreement, dated September 7, 2022, by and among the Registrant, Bank of America, N.A., and other lenders party thereto.8-K000-1586710.019/8/2022
10.24First Amendment to Loan Agreement, dated August 14, 2024, with respect to that certain Loan Agreement, dated September 7, 2022, by and among the Registrant, Bank of America, N.A. and the other lenders party thereto.8-K000-1586710.28/15/2024
10.25Loan Agreement, dated May 30, 2024, by and among the Registrant, Bank of America, N.A., and the other lenders party thereto.8-K000-1586710.16/3/2024
10.26First Amendment to Loan Agreement, dated August 14, 2024, with respect to that certain Loan Agreement, dated May 30, 2024, by and among the Registrant, Bank of America, N.A. and the other lenders party thereto.8-K000-1586710.38/15/2024
19.1The Registrant's Securities Trading Policy.X
21.1Subsidiaries of the Registrant.X
23.1Consent of PricewaterhouseCoopers LLP, Independent Registered Public Accounting Firm.X
24.1Power of Attorney (incorporated by reference to the signature page to this Annual Report on Form 10-K).
31.1Certification of the Registrant’s Chief Executive Officer, Anirudh Devgan, pursuant to Rule 13a-14 of the Securities Exchange Act of 1934.X
31.2Certification of the Registrant’s Chief Financial Officer, John M. Wall, pursuant to Rule 13a-14 of the Securities Exchange Act of 1934.X
32.1† · Certification of the Registrant’s Chief Executive Officer, Anirudh Devgan, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. · X
32.2† · Certification of the Registrant’s Chief Financial Officer, John M. Wall, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. · X
97.1The Registrant's Policy for Recovery of Erroneously Awarded Compensation.10-K000-1586797.012/14/2024
101.INSInline XBRL Instance Document.X
101.SCHInline XBRL Taxonomy Extension Schema Document.X
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document.X
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document.X
101.LABInline XBRL Taxonomy Extension Label Linkbase Document.X
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document.X
104Cover Page Interactive Data File - The cover page from this Annual Report on Form 10-K is formatted in iXBRL.
  • Indicates management contract or compensatory plan or arrangement covering executive officers or directors of the Registrant.

† In accordance with Item 601(b)(32)(ii) of Regulation S-K, the certifications furnished in Exhibits 32.01 and 32.02 hereto will not be deemed "filed" for purposes of Section 18 of the Exchange Act or incorporated by reference into any filings under the Securities Act or the Exchange Act (except to the extent that the registrant specifically incorporates it by reference).

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.